Zydus Lifesciences Ltd.

US Food and Drug Administration (USFDA) has conducted a surveillance inspection at Zydus Lifesciences’ formulation manufacturing plant located at Baddi in Himachal Pradesh. The inspection was conducted from August 4, 2025 to August 13, 2025.

The inspection concluded with 4 observations. There were no data integrity related observations. The company will closely work with the USFDA to address the observations expeditiously. 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.